On Thursday, May 26th, Vice President Joe Biden was ushered into MSK’s Rockefeller Research Laboratories to tour several of the labs, and then participate in a Cancer Moonshot panel discussion with Dr. Craig Thompson and several other MSK staff.
Shout-outs around the web to MSK researchers from ASCO:
- Bristol-Myers’s Drug Combination Boosts Lung Cancer Benefit – Dr. Matthew Hellman, CheckMate012 Study
- Immunotherapy Successful Handling Hard-to-Treat Cancer – Dr. Charles Rudin, Rova-T Study
- Eli Lilly & Co Issues Encouraging Update on Abemaciclib Phase 1 in Certain Metastatic Breast Cancer – Dr. Maura Dickler, MONARCH Study
A new fellowship in Breast Cancer Research at MSK has been established by Hunter Douglas, the window manufacturer. This graduate fellowship of $250,000 is supporting in the development of cutting edge and less invasive treatments to help breast cancer patients return to their normal lives more quickly.
MSK has once again been named to Becker’s 100 Great Hospitals in America for 2016. To be named to this list, one must be well-known for a variety of things, such as innovation, patient care, clinical advancement, and/or holding an irreplaceable spot in their communities. The Becker’s Hospital Review editorial team selects hospitals based on rankings and awards, and the final list considers overall healthcare leaders at the national, regional and state level.
Book Review: Managing Prostate Cancer: A Guide for Living Better by Dr. Andrew Roth. A “toolkit” for every man diagnosed with prostate cancer, Dr. Roth’s latest book details the entire process from diagnosis through survivorship to help men live healthier more meaningful lives during and after treatment, and to help men begin to think and discuss those hard topics. The book is complete with a variety of charts, graphs, and call-out boxes to help patients further understand complex concepts.